Organigram Holdings | OGI - 销售收入



金融业
股票价格
CAD
资产
CAD 521.31M
现金及等价物
CAD 4.29M
销售成本
CAD 43.39M
流动资产
CAD 250.09M
流动负债
CAD 88.75M
债务
CAD 8.2M
EBIT
CAD -9.79M
EBITDA
CAD -4.76M
员工
1.14K
EPS每股收益
CAD -0.01
股本和储备
CAD 371.81M
销售毛利
CAD 16.41M
债务利息支出
CAD 179K
贷款资金
CAD 60.76M
市值
CAD 154.93M
净收入
CAD -921K
营业费用
CAD 69.59M
营业利润
CAD -9.79M
普通股股本
CAD 136.47M
PE价格收益
12.01
税前利润
CAD -921K
销售收入
CAD 59.79M
销售和管理费用
CAD 22.01M
股票
CAD 135.16M
贸易债权人
CAD 73.14M
应收帐款人
CAD 53.39M


销售 更改 日
Acasti Pharma USD -4.76M 4.76M 2024-12
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Aurora Cannabis CAD 38.01M 56.18M 2026-03
Avita Medical AUD 17.61M 805K 2025-12
Canopy Growth CAD 71.25M 3.29M 2026-03
Cronos Group USD 53.01M 5.96M 2026-06
Dianthus Therapeutics USD 463K 179K 2026-03
Ionis Pharmaceuticals USD 268M 22M 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Moderna USD 100M 289M 2026-06
Organigram Holdings CAD 59.79M 3.74M 2026-03
Organon & Co USD 1.56B 100M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Viatris USD 3.76B 240M 2026-06
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03